16 min listen
How Solving a Problem with Genetic Medicines May Solve Another with Infectious Diseases
FromThe Bio Report
How Solving a Problem with Genetic Medicines May Solve Another with Infectious Diseases
FromThe Bio Report
ratings:
Length:
25 minutes
Released:
May 22, 2024
Format:
Podcast episode
Description
One of the challenges facing genetic medicines is delivering payloads across the human cell membrane and inside cells both effectively and with high tolerability. Aegis Life is capitalizing on its parent Entos Pharmaceuticals’ nucleic acid delivery platform technology to address infectious diseases. It recently secured investment from the Bill & Melinda Gates Foundation to help in the fight against malaria, HIV, and other conditions. We spoke to John Lewis, founder and CEO of Aegis Life, about the need it is addressing, the company’s platform technology, and how it is leveraging that to address the barriers to the delivery of vaccines and antibody therapies in developing economies.
Released:
May 22, 2024
Format:
Podcast episode
Titles in the series (100)
Why Patent Trolling Threatens Biopharma: The biopharmaceutical industry has long been considered immune to the threat of patent trolls, patent holders who seek to monetize the value of a patent through enforcement rather than productive use. But a paper by UC Hastings Robin Feldman and Harv... by The Bio Report